Explore the groundbreaking science of targeted protein degradation (TPD), a revolutionary strategy that hijacks the cell's natural disposal systems to eliminate disease-causing proteins.
Exploring how VHL protein dysfunction drives kidney cancer and the innovative therapies targeting this pathway.
Exploring how SCF E3 ubiquitin ligases function in cancer and the therapeutic strategies targeting these molecular complexes.
Discover how the first-in-class DOT1L PROTAC degrader MS2133 could revolutionize treatment for MLL-rearranged leukemia by completely eliminating the cancer-causing protein.
Discover how hypoxia-induced WSB1 protein drives osteosarcoma metastasis and the potential therapeutic strategies targeting this pathway.
Exploring how myostatin promoter polymorphisms could revolutionize Bali cattle breeding programs through enhanced muscling and fat deposition traits.
Exploring how the ubiquitin proteasome system regulates copper homeostasis and its implications in disease
Discover how selective autophagy receptors evolved redox-sensing capabilities to protect cells against oxidative stress and their implications for longevity and disease treatment.
Discover how Ulva prolifera algae survives extreme heat through molecular adaptations, revealed through cutting-edge proteomics research.
Unifying model explaining the versatile roles of ATG8 proteins in autophagy and cellular quality control